Clinical Trials Browser

Phase 1 × Small Cell Lung Carcinoma × Poly(ADP-ribose) Polymerase Inhibitors × Clear all

NCT03227016 2021-01-27

Study in Patients With SCLC of Veliparib in Combination With Topotecan

Phase 1 Unknown

Small Cell Lung Carcinoma